Norma Uribe

1.5k total citations
35 papers, 1.2k citations indexed

About

Norma Uribe is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Norma Uribe has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Norma Uribe's work include Hormonal Regulation and Hypertension (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Breast Lesions and Carcinomas (4 papers). Norma Uribe is often cited by papers focused on Hormonal Regulation and Hypertension (6 papers), Systemic Lupus Erythematosus Research (5 papers) and Breast Lesions and Carcinomas (4 papers). Norma Uribe collaborates with scholars based in Mexico, Spain and United States. Norma Uribe's co-authors include Norma A. Bobadilla, Gerardo Gamba, Victoria Ramírez, Rosalba Pérez‐Villalva, Cristino Cruz, Jonatan Barrera‐Chimal, Luz Graciela Cervantes-Pérez, Luciana Morla, Dario R. Alessi and Alain Doucet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The FASEB Journal and Kidney International.

In The Last Decade

Norma Uribe

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norma Uribe Mexico 17 423 371 273 237 184 35 1.2k
Katsuyuki Tanabe Japan 22 537 1.3× 237 0.6× 537 2.0× 178 0.8× 192 1.0× 68 1.5k
Lijun Sun China 15 556 1.3× 193 0.5× 792 2.9× 140 0.6× 248 1.3× 24 1.7k
Birgit Liliensiek Germany 11 600 1.4× 494 1.3× 316 1.2× 201 0.8× 103 0.6× 13 2.3k
Carine M. Boustany‐Kari United States 17 407 1.0× 262 0.7× 416 1.5× 104 0.4× 118 0.6× 20 1.3k
Ryohei Kaseda Japan 17 275 0.7× 252 0.7× 472 1.7× 89 0.4× 213 1.2× 39 1.1k
Ajay Kher United States 12 287 0.7× 100 0.3× 296 1.1× 123 0.5× 151 0.8× 26 994
Markus F. Neurath Germany 4 756 1.8× 260 0.7× 68 0.2× 187 0.8× 80 0.4× 7 1.7k
Patricia G. Vallés Argentina 21 508 1.2× 98 0.3× 268 1.0× 166 0.7× 95 0.5× 55 1.1k
Julián Rodrı́guez Spain 21 340 0.8× 190 0.5× 153 0.6× 139 0.6× 129 0.7× 88 1.2k
Irena Nowak United States 13 603 1.4× 217 0.6× 70 0.3× 58 0.2× 176 1.0× 18 2.1k

Countries citing papers authored by Norma Uribe

Since Specialization
Citations

This map shows the geographic impact of Norma Uribe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Uribe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Uribe more than expected).

Fields of papers citing papers by Norma Uribe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Uribe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Uribe. The network helps show where Norma Uribe may publish in the future.

Co-authorship network of co-authors of Norma Uribe

This figure shows the co-authorship network connecting the top 25 collaborators of Norma Uribe. A scholar is included among the top collaborators of Norma Uribe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Uribe. Norma Uribe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sánchez‐Navarro, Andrea, et al.. (2022). Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis. American Journal of Physiology-Renal Physiology. 323(4). F425–F434. 5 indexed citations
3.
Vega‐Vega, Olynka, et al.. (2022). Longitudinal Changes of Serum Creatine Kinase and Acute Kidney Injury among Patients with Severe COVID-19. International Journal of Nephrology. 2022. 1–9. 1 indexed citations
4.
Castañeda‐Bueno, María, Luz Graciela Cervantes-Pérez, Norma Vázquez, et al.. (2012). Activation of the renal Na + :Cl cotransporter by angiotensin II is a WNK4-dependent process. Proceedings of the National Academy of Sciences. 109(20). 7929–7934. 225 indexed citations
5.
Barrera‐Chimal, Jonatan, Rosalba Pérez‐Villalva, Roxana Rodríguez‐Romo, et al.. (2012). Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney International. 83(1). 93–103. 97 indexed citations
6.
Pérez‐Villalva, Rosalba, et al.. (2010). Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity. Nephrology Dialysis Transplantation. 25(7). 2150–2158. 16 indexed citations
7.
Ramírez, Victoria, Joyce Trujillo, Norma Uribe, et al.. (2009). Adrenalectomy prevents renal ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology. 297(4). F932–F942. 42 indexed citations
8.
Medina‐Franco, Heriberto, et al.. (2008). Radiofrequency Ablation of Invasive Breast Carcinomas: A Phase II Trial. Annals of Surgical Oncology. 15(6). 1689–1695. 49 indexed citations
9.
Pablo, Paola de, Rocío López-García-Torres, Norma Uribe, et al.. (2007). Kidney involvement in Takayasu arteritis.. PubMed. 25(1 Suppl 44). S10–4. 12 indexed citations
10.
Siles‐Lucas, Mar, Norma Uribe, Julio López‐Abán, et al.. (2007). The Schistosoma bovis Sb14-3-3ζ recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice. Vaccine. 25(41). 7217–7223. 21 indexed citations
11.
Uribe, Norma, Mar Siles‐Lucas, Julio López‐Abán, et al.. (2007). The Sb14-3-3ζ recombinant protein protects against Schistosoma bovis in BALB/c mice. Vaccine. 25(23). 4533–4539. 16 indexed citations
12.
Mejía‐Vilet, Juan M., Victoria Ramírez, Cristino Cruz, et al.. (2007). Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. American Journal of Physiology-Renal Physiology. 293(1). F78–F86. 104 indexed citations
13.
Uribe, Norma, Antonio Muro, Julio López‐Abán, et al.. (2007). Genetic and Immunological Characterization of the 14-3-3ζ Molecule From Schistosoma bovis. Journal of Parasitology. 93(4). 964–969. 5 indexed citations
14.
Pérez‐Rojas, Jazmin M., Cristino Cruz, Joyce Trujillo, et al.. (2006). Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. American Journal of Physiology-Renal Physiology. 292(1). F131–F139. 85 indexed citations
15.
Arroyo, Carlos, et al.. (2005). Metástasis poco frecuentes del carcinoma renal. Gaceta Médica de México. 141(6). 545–550.
16.
Medina‐Franco, Heriberto, et al.. (2005). [Fine needle aspiration biopsy of breast lesions: institutional experience].. PubMed. 57(3). 394–8. 13 indexed citations
17.
Trujillo, Joyce, Victoria Ramírez, Iván Torre-Villalvazo, et al.. (2004). Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. American Journal of Physiology-Renal Physiology. 288(1). F108–F116. 61 indexed citations
18.
Juárez, M. Patricia, Victoria Ramírez, Norma Uribe, et al.. (2003). Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney International. 63(1). 43–52. 123 indexed citations
19.
Uribe, Norma, et al.. (2001). Granulomatous amebic encephalitis by Balamuthia mandrillaris. 39(3). 141–148. 2 indexed citations
20.
Alberú, Josefina, et al.. (2001). Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients. Transplantation Proceedings. 33(1-2). 2024–2027. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026